Exagen Inc
NASDAQ:XGN

Watchlist Manager
Exagen Inc Logo
Exagen Inc
NASDAQ:XGN
Watchlist
Price: 2.51 USD -3.09% Market Closed
Market Cap: 43.6m USD
Have any thoughts about
Exagen Inc?
Write Note

Exagen Inc
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Exagen Inc
Change in Working Capital Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Exagen Inc
NASDAQ:XGN
Change in Working Capital
$3.6m
CAGR 3-Years
146%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Change in Working Capital
-$49m
CAGR 3-Years
70%
CAGR 5-Years
49%
CAGR 10-Years
5%
Gilead Sciences Inc
NASDAQ:GILD
Change in Working Capital
-$4.1B
CAGR 3-Years
-20%
CAGR 5-Years
-28%
CAGR 10-Years
-13%
Amgen Inc
NASDAQ:AMGN
Change in Working Capital
-$1.4B
CAGR 3-Years
-10%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Change in Working Capital
-$762.1m
CAGR 3-Years
-28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Change in Working Capital
-$721.7m
CAGR 3-Years
45%
CAGR 5-Years
-15%
CAGR 10-Years
N/A

See Also

What is Exagen Inc's Change in Working Capital?
Change in Working Capital
3.6m USD

Based on the financial report for Jun 30, 2024, Exagen Inc's Change in Working Capital amounts to 3.6m USD.

What is Exagen Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
146%

The average annual Change in Working Capital growth rates for Exagen Inc have been 146% over the past three years .

Back to Top